The complaint, filed by The Law Offices of Frank R. Cruz, centers on allegations that the medical technology company artificially inflated its financial performance. According to the suit, Procept implemented an aggressive discount program that incentivized customers to stockpile bulk handpiece orders. This practice reportedly obscured actual procedure demand and pulled revenue forward, creating a bubble in reported U.S. unit sales.
Investors Face Deadline in PROCEPT BioRobotics Securities Lawsuit
Investors who incurred financial losses holding PROCEPT BioRobotics Corporation stock between February 2024 and February 2026 have until September 22, 2026, to file as a lead plaintiff in a pending class action lawsuit alleging the company misled the market regarding its sales practices and inventory levels.
By the end of the class period, the lawsuit claims that customers held a surplus of more than 10,000 excess units. These overstocked inventory levels allegedly undermined the company’s public claims about its business operations and financial health. Investors seeking to participate or gather more information regarding their legal standing can contact the firm via email at info@frankcruzlaw.com or by calling 310-914-5007.
Comments (0)
No comments yet. Be the first!